| Product Code: ETC7663811 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Topical DrugsCDMO Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Topical DrugsCDMO Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Topical DrugsCDMO Market - Industry Life Cycle |
3.4 Israel Topical DrugsCDMO Market - Porter's Five Forces |
3.5 Israel Topical DrugsCDMO Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Israel Topical DrugsCDMO Market Revenues & Volume Share, By Service Type, 2021 & 2031F |
3.7 Israel Topical DrugsCDMO Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Israel Topical DrugsCDMO Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for topical drugs for various skin conditions and diseases in Israel |
4.2.2 Growing investments in research and development of advanced topical drug formulations |
4.2.3 Rise in outsourcing of drug manufacturing to Contract Development and Manufacturing Organizations (CDMOs) |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements and compliance standards for drug manufacturing in Israel |
4.3.2 Competition from established pharmaceutical companies offering in-house manufacturing capabilities |
5 Israel Topical DrugsCDMO Market Trends |
6 Israel Topical DrugsCDMO Market, By Types |
6.1 Israel Topical DrugsCDMO Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Topical DrugsCDMO Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Israel Topical DrugsCDMO Market Revenues & Volume, By Semi-solid Formulations, 2021- 2031F |
6.1.4 Israel Topical DrugsCDMO Market Revenues & Volume, By Liquid Formulations Drugs, 2021- 2031F |
6.1.5 Israel Topical DrugsCDMO Market Revenues & Volume, By Solid Formulations, 2021- 2031F |
6.1.6 Israel Topical DrugsCDMO Market Revenues & Volume, By Transdermal Products, 2021- 2031F |
6.2 Israel Topical DrugsCDMO Market, By Service Type |
6.2.1 Overview and Analysis |
6.2.2 Israel Topical DrugsCDMO Market Revenues & Volume, By Contract Development, 2021- 2031F |
6.2.3 Israel Topical DrugsCDMO Market Revenues & Volume, By Contract Manufacturing, 2021- 2031F |
6.3 Israel Topical DrugsCDMO Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Israel Topical DrugsCDMO Market Revenues & Volume, By Pharmaceutical Companies, 2021- 2031F |
6.3.3 Israel Topical DrugsCDMO Market Revenues & Volume, By Biopharmaceutical Companies, 2021- 2031F |
6.3.4 Israel Topical DrugsCDMO Market Revenues & Volume, By Others, 2021- 2031F |
7 Israel Topical DrugsCDMO Market Import-Export Trade Statistics |
7.1 Israel Topical DrugsCDMO Market Export to Major Countries |
7.2 Israel Topical DrugsCDMO Market Imports from Major Countries |
8 Israel Topical DrugsCDMO Market Key Performance Indicators |
8.1 Percentage increase in research and development expenditure by pharmaceutical companies in Israel |
8.2 Number of new partnerships and collaborations between CDMOs and pharmaceutical companies in Israel |
8.3 Growth in the number of patents filed for innovative topical drug formulations in Israel |
9 Israel Topical DrugsCDMO Market - Opportunity Assessment |
9.1 Israel Topical DrugsCDMO Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Israel Topical DrugsCDMO Market Opportunity Assessment, By Service Type, 2021 & 2031F |
9.3 Israel Topical DrugsCDMO Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Israel Topical DrugsCDMO Market - Competitive Landscape |
10.1 Israel Topical DrugsCDMO Market Revenue Share, By Companies, 2024 |
10.2 Israel Topical DrugsCDMO Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here